Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Arthur

Showing results (151-160 of 187) with videos related to

Pageof 19
Sort By:
Cancer Immunology Research|January 12, 2017
Temporally Distinct PD-L1 Expression by Tumor and Host Cells Contributes to Immune EscapeTakuro Noguchi, Jeffrey P Ward, Matthew M Gubin, et al.
The Journal of Experimental Medicine|September 21, 2011
Type I interferon is selectively required by dendritic cells for immune rejection of tumorsMark S Diamond, Michelle Kinder, Hirokazu Matsushita, et al.
Nature Communications|February 23, 2024
Complex regulatory networks influence pluripotent cell state transitions in human iPSCsTimothy D Arthur, Jennifer P Nguyen, Agnieszka D'Antonio-Chronowska, et al.
Science (New York, N.Y.)|January 12, 2019
Invertible promoters mediate bacterial phase variation, antibiotic resistance, and host adaptation in the gutXiaofang Jiang, A Brantley Hall, Timothy D Arthur, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
Analysis of regulatory network modules in hundreds of human stem cell lines reveals complex epigenetic and genetic factors contribute to pluripotency state differences between subpopulationsTimothy D Arthur, Jennifer P Nguyen, Agnieszka D'Antonio-Chronowska, et al.
Cell|May 20, 1998
Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responsesS J Rodig, M A Meraz, J M White, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 8, 2021
Radiation-induced neoantigens broaden the immunotherapeutic window of cancers with low mutational loadsDanielle M Lussier, Elise Alspach, Jeffrey P Ward, et al.
Annals of Surgical Oncology|July 16, 2022
Primary Tumor Resection is Associated with Improved Disease-Specific Mortality in Patients with Stage IV Small Intestinal Neuroendocrine Tumors (NETs): A Comparison of Upfront Surgical Resection Versus a Watch and Wait Strategy in Two Specialist NET CentersSonja Levy, James D Arthur, Melissa Banks, et al.
Blood|February 1, 1996
The human homologue of rat NG2, a chondroitin sulfate proteoglycan, is not expressed on the cell surface of normal hematopoietic cells but is expressed by acute myeloid leukemia blasts from poor-prognosis patients with abnormalities of chromosome band 11q23F O Smith, C Rauch, D E Williams, et al.
Blood|November 15, 1993
Prolonged subcutaneous administration of recombinant alpha 2b interferon in patients with previously untreated Philadelphia chromosome-positive chronic-phase chronic myelogenous leukemia: effect on remission duration and survival: Cancer and Leukemia Group B study 8583H Ozer, S L George, C A Schiffer, et al.
Pageof 19

Showing results (151-160 of 187) with videos related to

Sort By:
Pageof 19
Cancer Immunology Research|January 12, 2017
Temporally Distinct PD-L1 Expression by Tumor and Host Cells Contributes to Immune EscapeTakuro Noguchi, Jeffrey P Ward, Matthew M Gubin, et al.
The Journal of Experimental Medicine|September 21, 2011
Type I interferon is selectively required by dendritic cells for immune rejection of tumorsMark S Diamond, Michelle Kinder, Hirokazu Matsushita, et al.
Nature Communications|February 23, 2024
Complex regulatory networks influence pluripotent cell state transitions in human iPSCsTimothy D Arthur, Jennifer P Nguyen, Agnieszka D'Antonio-Chronowska, et al.
Science (New York, N.Y.)|January 12, 2019
Invertible promoters mediate bacterial phase variation, antibiotic resistance, and host adaptation in the gutXiaofang Jiang, A Brantley Hall, Timothy D Arthur, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
Analysis of regulatory network modules in hundreds of human stem cell lines reveals complex epigenetic and genetic factors contribute to pluripotency state differences between subpopulationsTimothy D Arthur, Jennifer P Nguyen, Agnieszka D'Antonio-Chronowska, et al.
Cell|May 20, 1998
Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responsesS J Rodig, M A Meraz, J M White, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 8, 2021
Radiation-induced neoantigens broaden the immunotherapeutic window of cancers with low mutational loadsDanielle M Lussier, Elise Alspach, Jeffrey P Ward, et al.
Annals of Surgical Oncology|July 16, 2022
Primary Tumor Resection is Associated with Improved Disease-Specific Mortality in Patients with Stage IV Small Intestinal Neuroendocrine Tumors (NETs): A Comparison of Upfront Surgical Resection Versus a Watch and Wait Strategy in Two Specialist NET CentersSonja Levy, James D Arthur, Melissa Banks, et al.
Blood|February 1, 1996
The human homologue of rat NG2, a chondroitin sulfate proteoglycan, is not expressed on the cell surface of normal hematopoietic cells but is expressed by acute myeloid leukemia blasts from poor-prognosis patients with abnormalities of chromosome band 11q23F O Smith, C Rauch, D E Williams, et al.
Blood|November 15, 1993
Prolonged subcutaneous administration of recombinant alpha 2b interferon in patients with previously untreated Philadelphia chromosome-positive chronic-phase chronic myelogenous leukemia: effect on remission duration and survival: Cancer and Leukemia Group B study 8583H Ozer, S L George, C A Schiffer, et al.
Pageof 19